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Background: Modulation of host miRNAs coincides
with increased pathogenicity in various infectious
diseases.
Results: miR-99b is up-regulated in M. tuberculosis-in-
fected dendritic cells, which inhibits production of proin-
flammatory cytokines.
Conclusion:Our findings unfold a novel immune evasion
strategy ofM. tuberculosis by modulating miRNAs.
Significance:Our study opens up the possibility to design
vaccines and immunotherapies for tuberculosis by target-
ing specific miRNAs.
Mycobacterium tuberculosis resides and replicates within
host phagocytes by modulating host microbicidal responses. In
addition, it suppresses the production of host protective cyto-
kines to prevent activation of and antigen presentation by
M. tuberculosis-infected cells, causing dysregulation of host
protective adaptive immune responses.Many cytokines are reg-
ulated by microRNAs (miRNAs), a newly discovered class of
small noncoding RNAs, which have been implicated in modu-
lating host immune responses in many bacterial and viral dis-
eases. Here, we show that miRNA-99b (miR-99b), an orphan
miRNA, plays a key role in the pathogenesis of M. tuberculosis
infection.We found thatmiR-99b expressionwashighly up-reg-
ulated in M. tuberculosis strain H37Rv-infected dendritic cells
(DCs) and macrophages. Blockade of miR-99b expression by
antagomirs resulted in significantly reduced bacterial growth in
DCs. Interestingly, knockdown of miR-99b in DCs significantly
up-regulated proinflammatory cytokines such as IL-6, IL-12,
and IL-1. Furthermore, mRNA andmembrane-bound protein
data indicated that inhibition of miR-99b augments TNF- and
TNFRSF-4 production. Thus, miR-99b targets TNF- and
TNFRSF-4 receptor genes. Treatment of anti-miR-99b-trans-
fectedDCswith anti-TNF- antibody resulted in increased bac-
terial burden. Thus, our findings unveil a novel host evasion
mechanism adopted byM. tuberculosis viamiR-99b, whichmay
open up new avenues for designing miRNA-based vaccines and
therapies.
Mycobacterium tuberculosis, the causative agent of tubercu-
losis (TB),3 remains one of the biggest global health problems,
with an estimated one-third of the global population latently
infected and more than 2 million deaths every year (1).
M. tuberculosis successfully combatsmicrobicidalmechanisms
of phagocytes to promote infection and replication and even
outmaneuvers these mechanisms to favor its persistence in
infected cells (2). Phagocytes, the primary innate immune cells
responding to M. tuberculosis, engulf microorganisms into
phagosomes, which later fuse with lysosomes (3). The acidic
environment of the phagolysosome degrades the harbored
organisms, and this process also makes antigens available for
priming of T cell responses (4, 5). M. tuberculosis resides and
replicates within phagocytes of susceptible hosts by avoiding
phagocytic destruction (6, 7). To survive within innate immune
cells, M. tuberculosis has evolved mechanisms to inhibit
phagolysosome fusion and to neutralize the acidic environment
of the phagolysosomal compartment (8). In addition to its
capacity to avoid phagolysosomal degradation,M. tuberculosis
successfully inhibits production of proinflammatory cytokines,
such as tumor necrosis factor- (TNF-) and interleukin-1 (IL-
1), as a means to prevent autocrine activation of infected cells
and to ensure persistence within the cells (9–12).
Immune responses to various infectiousmicroorganisms and
cancers are regulated at the post-transcriptional level by vari-
ous microRNAs (miRNAs) (13). It is now well documented
that production of several cytokines is regulated by miRNAs,
and these regulatory RNAs have therefore emerged as key
players in the immune system (14). miRNAs are an abundant
class of highly conserved small (18–25 nucleotides long)
noncoding RNAs that suppress gene expression by binding
to the 3-untranslated region (UTR) of target mRNAs (15). A
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direct role of miRNAs in innate immunity was revealed by
the identification of miR146a as a negative feedback regula-
tor in Toll-like receptor signaling by targeting IL-1R-associ-
ated kinase 1 (IRAK1) and TNF receptor-associated factor 6
(TRAF6). miR-146a inhibits the expression of IRAK1 and
TRAF6 and impairs nuclear factor-B (NF-B) activity,
which in turn suppresses the expression of IL-6, IL-8, IL-1,
and TNF- (13, 15–18). A recent study further suggested
that lipomannan from virulent M. tuberculosis but not from
avirulent Mycobacterium smegmatis is a potent inhibitor of
TNF- biosynthesis in human macrophages, by regulating
miR-125b and miR-155 expression via the inositol phospha-
tase SHIP-1 (19). Taken together, these data suggest a cor-
relation between miRNA expression and cytokine regulation
during M. tuberculosis infection.
We have performed a detailed investigation of the role of
miRNAs in M. tuberculosis infection and pathogenesis.
Microarray analysis suggested that eight different miRNAs
were up-regulated in M. tuberculosis-infected DCs. However,
only miR-99b was highly up-regulated by M. tuberculosis-in-
fected DCs but not by lipopolysaccharide (LPS)-stimulated
DCs, and this was dependent onMyD88 signaling. Knockdown
of miR-99b in DCs significantly reduced the bacterial burden.
Moreover, blocking miR-99b by synthetic antagomirs
enhanced the production of IL-6, IL-12, and IL-1. We further
showed that miR-99b targets various mRNA transcripts,
including TNFRSF-4 and TNF-, to regulate expression of
various cytokines and transcription factors involved in T cell
lineage differentiation pathways and in the clearance of
M. tuberculosis bacteria. Blockade of TNF- in anti-miR-99b-
transfected DCs significantly increased the burden ofM. tuber-
culosis infection, providing evidence for a critical role of TNF-
as a target for miR-99b. Therefore, our findings provide evi-
dence that M. tuberculosis inhibits the activation of infected
cells by up-regulating miR-99b expression, which represents a
novel strategy adopted byM. tuberculosis to evade host protec-
tive immune responses that allows these organisms to survive
within phagocytes.
EXPERIMENTAL PROCEDURES
Mice—C57BL/6 mice (6–8 weeks of age) were initially pur-
chased from The Jackson Laboratory. MyD88 knock-out mice
were a kind gift from Prof. Ruslan Medzhitov, Yale University,
School of Medicine. All animals were subsequently bred and
maintained in our specific pathogen-free animal facility at the
International Centre for Genetic Engineering and Biotechnol-
ogy (ICGEB), New Delhi, India.
DC Preparation—DCs were prepared as described earlier
(20) and in the supplemental Methods.
H37Rv Bacterial Infections—DCswere prepared fromWTor
MyD88-deficient C57BL/6 mice as described above. Infection
experiments were performed in 24-well plates (Nunc). DCs
were infected in complete RPMImediumwithout antibiotics at
a finalmultiplicity of infection of 10H37RvM. tuberculosisbac-
teria (multiplicity of infection of 1:10; DCs:H37Rv). DCs were
incubated for another 24 h at 37 °C in a 5% CO2 humidified
incubator. For control experiments, DCs were also cultured in
the presence or absence of LPS at 1 g/ml. Culture superna-
tants were collected at 24 h from uninfected, LPS-treated,
H37Rv-infected and LPSH37Rv-treated DCs and kept at
80 °C until used for cytokine analysis.
miRCURY LNATM-based miRNA Microarrays—Total RNA
was isolated by miRNeasy isolation kit (Qiagen) according to
the manufacturer’s instructions, andmicroRNA profiling anal-
ysis was performed by EXIQON, Vedbaek, Denmark.
q-PCRAnalysis of miRNAExpression—Total RNA, including
miRNAs, was isolated by miRNeasy isolation kit (Qiagen), and
cDNA was synthesized separately for miRNAs and mRNA for
real-time quantitative PCR (q-RT-PCR). q-RT-PCR analysis
was performed using Bio-Rad CFX96 real-time thermal cycler
(Bio-Rad) and miRCURY LNA universal reverse transcriptase
microRNA PCR SYBR Green master mix (EXIQON) for
miRNA (miR-146a miR-125a-5p and miR-99b) amplification
and iQTM Bio-Rad SYBR Green master mix (Bio-Rad) for
TNF- and TNFRSF-4 expression as recommended by the
manufacturers. Detailed protocols are provided in the supple-
mental Methods.
Knockdown of miRNAs Using Antagomirs—For transfection
of anti-miR-99b (antagomirs) and scramble control (EXIQON),
DCswere transfected at day 4 of culture in antibiotic-free RPMI
1640 using LipofectamineTM 2000 (Invitrogen) reagents.
Briefly, at day 4 of culture, DCs were washed once with antibi-
otic-free RPMI 1640 medium and cultured in 500 l of antibi-
otic-free RPMI 1640medium for 4 h in a humidified CO2 incu-
bator at 37 °C. Four hours later, 100 nM of antagomirs or
scramble control were added into 50 l of Opti-MEMmedium
(Invitrogen) according to the manufacturer’s instructions. The
next day, medium was changed, and DCs were subjected to
H37Rv bacterial infections. These DCs were called knockdown
DCs. After 24 h of bacterial infection, DCs were harvested for
RNA preparation and quantitative real-time PCR for miR-99b,
TNFRSF-4, and TNF-.
Determination of H37Rv Colony-forming Units in DC
Cultures—DCs (0.5  106) were grown in 24-well plates
(Nunc), transfected with anti-miR99b or scramble control
antagomirs, and infected with H37Rv bacteria as described
above. In some experiments 10 g/ml anti-TNF- antibody
(Santa Cruz Biotechnology) was added to the DC cultures.
After 48 h, 250 l of lysis buffer (0.05% SDS in 7H9 medium)
was added andmixedwell, and the cellswere left in contactwith
lysis buffer. After 5 min of incubation, 10- and 100-fold dilu-
tions were made in a 96-well plate, and 10 l of each dilution
was plated on square plates (Bio-Rad) using trailing methods.
Detection of Cytokines—DCcytokines in the culture superna-
tant were assayed by a Luminex microbead-based multiplexed
(Qiagen Luminex LiquiChip) assay using commercially avail-
able kits according to the manufacturer’s protocol (Bio-Plex,
Bio-Rad).
Statistical Analysis—Paired t tests and analysis of variance
and Tukey’s post hoc test were performed to compare the sta-
tistical significance between various groups. p values were con-
sidered significant if p  0.05, and S.D. is shown in all figures
unless stated otherwise. In some cases, GraphPad Prism5.0
software was used for statistical analyses.
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RESULTS ANDDISCUSSION
It has been well established that M. tuberculosis infects
macrophages and DCs. DCs are the most potent antigen-pre-
senting cells of the immune system and thus determine the
outcome of adaptive immune responses during infection.
Therefore, we infected DCs with M. tuberculosis and deter-
mined the expression of miRNAs by miRCURY LNATM
miRNA microarray profiling. We generated DCs from bone
marrow precursor cells following culture with IL-4 and GM-
CSF as described elsewhere (20). At day 5, DCs were infected
with virulent H37Rv bacteria. As a control, parallel DC cultures
were activated with LPS. The miRCURYTM LNA miRNA
microarray data revealed that eight miRNAs (miR-710, miR-
881*, miR-882, miR-877, miR-146a, miR-125a-5p, miR-99b,
and miR-222) were up-regulated in the M. tuberculosis-in-
fectedDCs.Among these,miRNAsmiR-146a andmiR-125a-5p
were LPS- and H37Rv-induced, and the other miRNAs, miR-
710, miR-881*, miR-882, miR-877, and miR-99b, appeared to
be preferentially induced by H37Rv as compared with LPS (Fig.
1B). Interestingly, only miR-99b was highly up-regulated in
DCs by M. tuberculosis infection but not by LPS, and this was
also dependent on MyD88 expression, as demonstrated with
DCs from MyD88-deficient mice (Fig. 1A). Previously, it has
been shown that MyD88-deficient animals are hypersuscepti-
ble toM. tuberculosis infection (21, 22). Our findings therefore
raised the possibility that miR-99b regulates cytokine expres-
FIGURE 1. Differential expression of miRNAs inM. tuberculosis-infected dendritic cells. A, heat map diagram showing the result of two-way hierarchical
clustering of genes and samples. Each row represents anmiRNA, and each column represents a sample. The clustering is performed on log2 (Hy3/Hy5) ratios,
which passed the filtering criteria on variation across samples within each group:  log median ratio 1.0 equal to -fold change2.0. Only 19 out of 599
miRNAs passed the filtering criteria on variation across samples. The color scale shownat the bottom illustrates the relative expression level of anmiRNAacross
all samples; red color represents an expression level above the mean, and blue color represents expression lower than the mean. Eight different miRNAs were
up-regulated after M. tuberculosis infection as compared with uninfected (U) control, and two miRNAs were down-regulated as compared with control in
C57BL/6 mice. Most of the miRNAs that were up-regulated in C57BL/6 mice were induced at lower levels in MyD88/ mice. B, real-time expression of
miR-146a,miR-125a-5p, andmiR-99b inWTdendritic cells afterM. tuberculosis (H37Rv) infection, LPS treatment, or treatmentwith LPSH37Rv. Student’s t test
wasperformed tomeasure the statistical significancebetweenuninfected cells, infected cells, LPS-treated cells, or cells treatedwithboth LPS andH37Rv. *,p
0.05, **, p 0.01. All miRNAswere detected by real-time RT-PCR, and 5 S rRNAwas used as an internal control to normalize the relative amount ofmiRNA. The
2Ct method was used to calculate the -fold expression. Data shown here are mean S.D. for one representative experiment of at least 3–4 independent
experiments. C, DCs were subjected to antagomirs for blocking miR-99b, miR-146a, or miR-125a-5p expression, and scrambled antagomirs were used as a
control. After 48 h of H37Rv bacterial infection, cells were lysed, and 10- and 100-fold dilutions were made and then plated on square plates using trailing
methods. Student’s t testwas performed; **,p 0.01. Data shownhere are representative of 2 independent experiments.D, DCswere subjected tomiRmimics
for overexpression of miR-99b and mimic control. In parallel, DCs were subjected to antagomirs for blocking miR-99b and a scramble control. After 48 h of
H37Rv bacterial infection, cells were lysed, and 10- and 100-fold dilutions weremade and then plated on square plates using trailingmethods. Student’s t test
was performed; **, p 0.01. Data shown here are representative of 2 independent experiments.
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sion and determines susceptibility or resistance toM. tubercu-
losis infection. Therefore, wemainly focused on the role ofmiR-
99b in the pathogenesis of M. tuberculosis infection. Some of
themiRNAs, such asmiR-762, miR-290-5p, andmiR-665, were
down-regulated in M. tuberculosis-infected DCs. To corrobo-
rate our miRNA microarray profiling data, we performed
q-PCR for detecting the expression levels of these miRNAs in
infected DCs. Consistent with the microarray profiling results,
both miR-146a and miR-125a-5p were up-regulated in the
presence of H37Rv bacteria (miR-146a, p 0.02; miR-125a-5p,
p 0.03) or LPS (miR-146a, p 0.03; miR-125a-5p, p 0.04)
(Fig. 1C). Furthermore, when both LPS and H37Rv were pres-
ent, we observed a cumulative induction of these miRNAs
(miR-146a, p 0.02; miR-125a-5p, p 0.01), which confirmed
the miRNA profiling data (Fig. 1B). These data therefore sug-
gested that M. tuberculosis H37Rv bacteria modulate the
expression of miRNAs to promote survival inside host cells.
Furthermore, q-PCRdata confirmed thatmiR-99bwas the least
sensitive to LPS induction, as predicted by miRNA microarray
analysis, and this is consistent with results from a recent study
performed with macrophages (23). However, miR-99b was sig-
nificantly up-regulated in DCs in the presence of H37Rv bacte-
ria (p 0.01) (Fig. 1B), indicating that induction of miR-99b in
DCs was specific toM. tuberculosis infection.
To address the question whether enhanced miRNA expres-
sion supports the growth of bacteria, we performed loss-of-
function miRNA experiments. For this purpose, we employed
synthetic antagomirs to investigate the effect of miRNA knock-
down on the production of various cytokines produced by DCs.
Transfection efficiency of miR-99b antagomirs was95% in all
experiments (supplemental Fig. 1A). To examine the knock-
down (KD) efficiency, we performedmiRNA-q-PCR and found
statistically significant inhibition of all three miRNAs (miR-
99b, miR-146a, andmiR-125a-5p) in different treatments (sup-
plemental Fig. 1B). Once we confirmed the KD efficiency for
different miRNAs, we investigated the bacterial burden in
antagomir-transfected DCs infected with H37Rv and found
that inhibition of miR-99b enhanced the clearance of bacteria
from infected cells as compared with scramble controls,
whereas KD of other miRNAs (miR-146a andmiR-125-5p) had
no effect on bacterial growth. At 48 h after infection, there was
a statistically significant reduction in the growth of H37Rv bac-
teria (p 0.01) inDCs treatedwith anti-miR-99b antagomirs as
compared with the scramble control (Fig. 1C). Furthermore,
when we overexpressed miR-99b by miRNA mimics, we failed
to observe a statistically significant enhancement in bacterial
growth as compared with mimic controls (Fig. 1D). We specu-
late that bacteria themselves induce miR-99b levels in the
infectedDCs and that thismiRNAmight therefore already have
reached a saturated level. Thus, overexpression of miRNA does
not enhance bacterial growth.Overall, our findings suggest that
KD of miR-99b is essential for reduced survival of bacteria.
In the preceding section, we showed that blockade ofmiR99b
expression resulted in restriction of bacterial growth. There-
fore, we hypothesized that miRNA knockdown would enhance
cytokine secretion byDCs. Previous studies have suggested that
variousM. tuberculosis strains (virulent and avirulent) differen-
tially induce production of distinct cytokines such as IL-6,
IL-12, IL-1, and TNF- (20, 24, 25). In agreement with previ-
ous findings, we found comparable production of IL-6 and
IL-12 in DCs infected with the H37Rv strain ofM. tuberculosis
(Fig. 2A) (20). Surprisingly, KD of miR-99b in uninfected DCs
also significantly up-regulated IL-6 (p  0.04), IL-12p40 (p 
0.001), IL-12p70 (p  0.03), and IL-1 (p  0.05) production
(Fig. 2A). Thus, these data suggested that even at basal levels,
inhibition of miR-99b can cause an enhancement in cytokine
production. Further, we have found that KD of miR-99b in
H37Rv-infected DCs significantly up-regulates IL-6 (p 0.01),
IL-12p40 (p 0.01), IL-12p70 (p 0.04), and IL-1 (p 0.04)
production (Fig. 2A). These data suggested that miR-99b plays
a critical role in regulating cytokine production in DCs.
To determine which key signaling molecules are affected by
miR-99b duringM. tuberculosis infection in DCs, we explored
possible targets related to Toll-like receptor signaling, cytokine
signaling, and autophagolysosomal pathways. For this purpose,
we have employed various computational algorithms to iden-
tify potential targets (supplemental Fig. 2). It has been estab-
lished that based on the predicted seed-match sequences (7–8-
nucleotide homology matches), each miRNA has several
potential false positive target sites. We found that TNF- and
TNFRSF-4 have potential matches for miR-99b (supplemental
Fig. 3A). Therefore, we next performed q-PCR and Western
blot analyses for TNF- and TNFRSF-4 to test the targets of
miR-99b.
Consistent with previous findings suggesting that miRNAs
are post-transcriptional regulators of mRNAs (13, 14), we
found that miR-99b has a TNF receptor superfamily member-4
(TNFRSF-4, OX40, or CD134) as a target site, which was signif-
icantly up-regulated (p 0.03) in the presence of bacteria after
miR-99b KD (Fig. 2B). Inhibition/overexpression of miR-99b
affects TNFRSF-4 protein expression as well (Fig. 2C and sup-
plemental Fig. 3, B andD). Furthermore, mRNA transcripts for
TNF-, a keymolecule in eliminating the bacterial burden from
the infected cells, were also significantly up-regulated (p 
0.01) after M. tuberculosis infection (Fig. 2B). TNF- was fur-
ther validated as a target for miR-99b at the protein level by
immunoblotting of M. tuberculosis-infected DCs with scram-
ble control ormiR-99b antagomirs, which suggested that KD of
miR-99b enhanced total TNF- protein production (Fig. 2C
and supplemental Fig. 3, B and C). To further confirm that
TNF- is targeted by miR-99b, we performed luciferase assays
to measure 3-UTR luciferase protein activity. To perform the
luciferase assay, we have cloned the 3-UTR of TNF- into
pGL-3 vector downstream of the luciferase gene. 293T cells
were transfected with miR-99b construct, control vectors and
pGL-3-3-UTR-TNF vector as described under “Experimental
Procedures.” Luciferase activity was 17% reduced when the
3-UTRs of TNF- and miR-99b were both present as com-
pared with control miRNAs (miR-C) or nontargeted miR-21 in
the presence of TNF-. This experiment revealed that TNF- is
indeed a bona fide target ofmiR-99b (Fig. 2D). Furthermore, we
overexpressed miR-99b in CD4 T cells, differentiated these
cells into T helper (Th1) cells, andmeasured TNF- and IFN-
production. As anticipated, overexpression of miR-99b
reduced expression of TNF- protein but did not alter IFN-
production (supplemental Fig. 4). Thus, TNF- expression is
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regulated upon KD and overexpression of miR-99b. Hence, our
data provide substantial evidence that TNF- is one of the vital
genes targeted by miR-99b. Nevertheless, despite observing
increased levels of mRNA transcripts and enhanced levels of
membrane-bound and intracellular TNF- protein, we were
unable to detect significant changes in secreted TNF- protein
upon infection of DCs withM. tuberculosis (supplemental Fig.
3E), for reasons that remain unclear. Thus, although there is
unequivocal evidence that miR-99b regulates TNF-, there are
likely additional factors that influence TNF- secretion or reg-
ulatory feedback mechanisms. This might also partly explain
why treatment with mimic miR-99b does not lead to a signifi-
cant increase in CFU in H37Rv-infected DCs (Fig. 1D). None-
theless, it has previously been shown that TNF--deficient
mice are hypersusceptible to M. tuberculosis infection (12).
Therefore, KD of certain miRNAs might permit the host to
resist M. tuberculosis infection. Thus, our results indicate that
various miRNAs control different signaling pathways and that
modulation of their expression byM. tuberculosispermits these
organisms to evade host immunity and survive inside DCs and
macrophages.
To determine whether TNF- plays a critical role in control-
ling bacterial growth following miR-99b KD, we neutralized
TNF- production in the cultures with anti-TNF- antibody.
In Fig. 2E, scrambled control sample infected with H37Rv was
employed as a positive control for the experiment testing the
effect of anti-miR-99b on bacterial burden of H37Rv in DCs, as
well as for scrambled control sample treated with anti-TNF-.
FIGURE 2. Blockade of miRNA expression by antagomirs up-regulates multiple cytokines. A, dendritic cells were treated with miR99b antagomirs after
M. tuberculosis (H37Rv) infection. Culture supernatants were analyzed for cytokines bymultiplex Luminexmethod. Student’s t test was performed; *, p 0.05,
**, p 0.01. Data shown here are mean S.D. for a representative experiment of at least 4 independent experiments. U, uninfected. B, dendritic cells were
treated with miR-99b antagomirs and then infected withM. tuberculosis (H37Rv). Gene expression of candidate targets of miR-99b was assessed by q-RT-PCR
after 24 h of H37Rv infection. TNFRSF-4 and TNF-mRNA transcript is shown. Student’s t test was performed to compare mRNA transcript expression levels
between the scramble control andmiR-99bknockdown samples; *,p0.05, **,p0.01.DCswere treatedwithmiR-99bantagomirs, and scramble antagomirs
were used as a control. C, Western blotting for TNF-was performed fromDCs infected withM. tuberculosis and treated with the scramble control or miR-99b
KD samples. Protein blot data suggested that miR-99b KD samples have higher TNF- expression as compared with the scramble control. A similar trend was
also observed for TNFRSF-4 (48 kDa) protein expression. Protein was quantified using ImageJ software (TNF-/-actin or TNFRSF-4/-actin). Data shown here
are representative of 2 independent experiments. D, as shown in the figure, when the 3-UTR of TNF andmiR-99 were present in the cells, a 17% reduction in
luciferase activity was observed as comparedwith controlmiR aswell as control pGL-3 vector co-transfectedwithmiR-99 (*, p 0.03). Therewas no change in
luciferase activity inducedbymiR-21 co-transfectedwithpGL-3 or pGL-3-TNF-3-UTR vectors. Data shownhere summarize 3 independent experiments. E, after
48 h of H37Rv bacterial infection, bacterial growth was measured. Scramble-treated DCs act as a control, showing higher bacterial burden as compared with
DCs treatedwithmiR-99bLNA-anti-miRprobes (*,p0.04).miR-99bknockdownsampleswere supplementedwith anti-TNF- antibody toblock TNF-, which
showed increased H37Rv (Rv) bacterial growth as compared with the miR-99b knockdown samples as well as scramble control samples (*, p  0.02). Data
shown here are representative of 2 independent experiments.
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Our data suggested that treatment of scrambled control sample
with anti-TNF- antibodymodestly enhanced bacterial growth
as compared with DCs treated with scrambled control only.
Knockdown of miR-99b in DCs significantly reduced bacterial
growth because of an increase in the production of various pro-
inflammatory cytokines (e.g. IL-1, TNF-, etc.). To determine
whether TNF- has a specific role in bacterial survival, we
added an anti-TNF- antibody to H37Rv-infected DCs with
miR-99b knockdown (Fig. 2E). Neutralization of TNF-
resulted in an increase in bacterial burden in these cultures.
Hence, TNF- is critical for reduced bacterial burden as it was
produced in the absence of miR-99b. Thus, altogether these
data confirmed that miR-99b affects bacterial growth in
M. tuberculosis-infected DCs by modulating TNF- produc-
tion, which activates DCs to clear the engulfed bacteria.
In summary, our data reveal a novel role of miR-99b in mod-
ulating host immunity after M. tuberculosis infection by con-
trolling TNF- production. Furthermore, miR-99b could
potentially serve as a therapeutic and diagnostic tool in TB
infection. However, to design vaccines and DC-based therapies
for TB, further in vivo studies will be needed to confirm the
potential roles of miR-99b and other miRNAs in active TB
infections in murine models and human patients.
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